CVE-2022-21338 Details
Description
Vulnerability in the Oracle Communications Convergence product of Oracle Communications Applications (component: General Framework). The supported version that is affected is 3.0.2.2.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Communications Convergence. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Communications Convergence accessible data as well as unauthorized read access to a subset of Oracle Communications Convergence accessible data. CVSS 3.1 Base Score 4.6 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:L/A:N).
Metrics
CVSS 4.0 Severity and Vector Strings:
No CVSS 4.0 data is available for this CVE.
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
CISA-ADP
Assessed Sep 24, 2024References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
| URL | Source(s) | Tag(s) |
|---|---|---|
| https://www.oracle.com/security-alerts/cpujan2022.html | CVE | Vendor Advisory |
| https://www.oracle.com/security-alerts/cpujan2022.html | [email protected] | Vendor Advisory |
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| NVD-CWE-noinfo | Insufficient Information to Classify Weakness | [email protected] |
Affected Products
| Product | Versions |
|---|---|
| oracle communications convergence | 3.0.2.2.0 |
CPE
Remediation
| |
Change History
5 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Nov 21, 2024 | CVE Modified | CVE |
| May 14, 2024 | CVE Modified | [email protected] |
| Jan 24, 2022 | Initial Analysis | [email protected] |